Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.2B | 3.8B | 6.5B | 4.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 11M | — | 12M | 11M |
| Other operating expenses | 116M | — | 114M | 116M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 167M | — | 142M | 129M |
| Other income expense | 4M | 10M | 4M | 3M |
| Pretax income | 934M | 1.2B | 1.7B | 1.0B |
| Tax provision | 175M | 71M | 191M | 161M |
| Net income | 759M | 1.1B | 1.5B | 866M |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 759M | 1.1B | 1.5B | 866M |
| Minority interests | -294M | -64M | -859M | -237M |
| Preferred stock dividends | — | — | — | — |